text: FEATURED VIDEO: CODENTIFY®
  FEATURED VIDEO: DIAGEO BAILEYS
  FEATURED VIDEO: VIDEOJET CLEANFLOW™ TECHNOLOGY
  An independent survey carried out with over 2000 professionals in the Pharmaceutical and Medical industry identifies where manufacturers are positioned on the road to implementing serialization.
  See what they had to say.
  58% of all sites have lines impacted by FMD
  (Falsified Medicines Directive) or DSCSA
  (Drug Supply Chain Security Act)
  All have one line impacted, 10% have more than 15
  Nearly half the lines (48%) are yet to be ‘Serialization Ready
  75% of lines impacted by legislation see approximately half the product being placed in a carton.
  At least 75% of lines impacted by serialization require product to be bundle wrapped for aggregation.
  For 66% of the lines that are not ‘Serialization Ready’…
  66% of the lines that are not ‘Serialization Ready’ no action is planned for the next 12 months!
  69% will be looking for a standard serialization approach across all lines
  60% of responders will acquire their Serialization Printer direct from the printer manufacturer, another 26% will get theirs from a Serialization integrator
  77% of Pharma Manufacturers likely to
  Meeting future compliance needs
  White paper on pharmaceutical packaging serialization
  Thermal inkjet solutions for global track and trace
  *Independent Research conducted by TechValidate Survey 8th September 2015 TVID: 7F9 8DB 2C5
  © 2018 Videojet Technologies, Inc.
  Thank you for your interest in our product.Download:
explanation: The document is a summary of an independent survey conducted in the pharmaceutical and medical industry, focusing on the implementation of serialization. It includes various statistics and percentages related to the impact of serialization on production lines, compliance with regulations, and future plans for serialization. The document does not contain any math questions or answers.
distilabel_metadata.content: Evaluate the user given text extract and determine if it contains a math question and optionally and answer to this question.
  
  Output rules:
  
  1. Briefly describe the document and mention if it contains a question or a question and answer.
  2. Finalize the output with: Label: no-question,question,question-and-answer,multiple-question,multiple-question-and-answer
distilabel_metadata.role: system
distilabel_metadata.content: FEATURED VIDEO: CODENTIFY®
  FEATURED VIDEO: DIAGEO BAILEYS
  FEATURED VIDEO: VIDEOJET CLEANFLOW™ TECHNOLOGY
  An independent survey carried out with over 2000 professionals in the Pharmaceutical and Medical industry identifies where manufacturers are positioned on the road to implementing serialization.
  See what they had to say.
  58% of all sites have lines impacted by FMD
  (Falsified Medicines Directive) or DSCSA
  (Drug Supply Chain Security Act)
  All have one line impacted, 10% have more than 15
  Nearly half the lines (48%) are yet to be ‘Serialization Ready
  75% of lines impacted by legislation see approximately half the product being placed in a carton.
  At least 75% of lines impacted by serialization require product to be bundle wrapped for aggregation.
  For 66% of the lines that are not ‘Serialization Ready’…
  66% of the lines that are not ‘Serialization Ready’ no action is planned for the next 12 months!
  69% will be looking for a standard serialization approach across all lines
  60% of responders will acquire their Serialization Printer direct from the printer manufacturer, another 26% will get theirs from a Serialization integrator
  77% of Pharma Manufacturers likely to
  Meeting future compliance needs
  White paper on pharmaceutical packaging serialization
  Thermal inkjet solutions for global track and trace
  *Independent Research conducted by TechValidate Survey 8th September 2015 TVID: 7F9 8DB 2C5
  © 2018 Videojet Technologies, Inc.
  Thank you for your interest in our product.Download:
distilabel_metadata.role: user
distilabel_metadata.raw_output_q_a_detector_0: The document is a summary of an independent survey conducted in the pharmaceutical and medical industry, focusing on the implementation of serialization. It includes various statistics and percentages related to the impact of serialization on production lines, compliance with regulations, and future plans for serialization. The document does not contain any math questions or answers.
  
  Label: no-question